BIOMAT Database Logo BIOMAT Database Logo

Rapid decrease in cyclic 3'5'-guanosine monophosphate in the earliest phase of acute myocardial infarction. 1989

S Hauptlorenz, and M Wencker, and P Lechleitner, and F Dienstl, and B Puschendorf
Institut f. Med. Chemie u. Biochemie, Universität Innsbruck, Austria.

UI MeSH Term Description Entries
D008297 Male Males
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D006152 Cyclic GMP Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed) Guanosine Cyclic 3',5'-Monophosphate,Guanosine Cyclic 3,5 Monophosphate,Guanosine Cyclic Monophosphate,Guanosine Cyclic-3',5'-Monophosphate,3',5'-Monophosphate, Guanosine Cyclic,Cyclic 3',5'-Monophosphate, Guanosine,Cyclic Monophosphate, Guanosine,Cyclic-3',5'-Monophosphate, Guanosine,GMP, Cyclic,Guanosine Cyclic 3',5' Monophosphate,Monophosphate, Guanosine Cyclic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

S Hauptlorenz, and M Wencker, and P Lechleitner, and F Dienstl, and B Puschendorf
Plasma cyclic adenosine 3'5'-monophosphate (AMP) levels in acute myocardial infarction.
July 1974, The American journal of cardiology,
S Hauptlorenz, and M Wencker, and P Lechleitner, and F Dienstl, and B Puschendorf
Cerebrospinal fluid cyclic guanosine 3'5' monophosphate levels in Parkinson's disease.
February 1998, Journal of the neurological sciences,
S Hauptlorenz, and M Wencker, and P Lechleitner, and F Dienstl, and B Puschendorf
Characterization and metabolism of cyclic guanosine 3'5'-monophosphate in Mycobacterium smegmatis.
June 1984, Biochemical and biophysical research communications,
S Hauptlorenz, and M Wencker, and P Lechleitner, and F Dienstl, and B Puschendorf
Guanosine 3'5' cyclic monophosphate is a potent pituitary growth hormone secretogogue.
January 1972, Endocrinology,
S Hauptlorenz, and M Wencker, and P Lechleitner, and F Dienstl, and B Puschendorf
The earliest phase of acute myocardial infarction in man.
March 1973, Acta medica Scandinavica,
S Hauptlorenz, and M Wencker, and P Lechleitner, and F Dienstl, and B Puschendorf
Arrhythmias in the earliest phase of acute myocardial infarction.
October 1974, Acta medica Scandinavica,
S Hauptlorenz, and M Wencker, and P Lechleitner, and F Dienstl, and B Puschendorf
[Concentration of cyclic adenosine-3'5'-monophosphate and guanosine-3'5'-monophosphate in placental cells during physiologic and complicated pregnancy and during labor].
January 1984, Akusherstvo i ginekologiia,
S Hauptlorenz, and M Wencker, and P Lechleitner, and F Dienstl, and B Puschendorf
Assessment of hypervolemia by cyclic 3'5'-guanosine monophosphate in pediatric patients on hemodialysis.
January 1999, Nephron,
S Hauptlorenz, and M Wencker, and P Lechleitner, and F Dienstl, and B Puschendorf
[Biological role of 3'5'-guanosine monophosphate (cGMP)].
January 1977, Postepy higieny i medycyny doswiadczalnej,
S Hauptlorenz, and M Wencker, and P Lechleitner, and F Dienstl, and B Puschendorf
Relationship between atrial natriuretic polypeptide and cyclic 3'5'-guanosine monophosphate in human plasma.
June 1987, The Journal of laboratory and clinical medicine,
Copied contents to your clipboard!